National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA08	VOTUM	B	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	753,896 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	908,603 L.L
L01EG02	AFINITOR	B	Everolimus - 5mg	5mg	Tablet	149,280,650 L.L
N06AA21	LUDIOMIL	B	Maprotiline - 10mg	10mg	Tablet, sugar coated	867,738 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
C05CX	TANAKAN	B	Ginkgo biloba - 40mg	40mg	Tablet, film coated	1,662,333 L.L
J07BH01	ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT	B	Rotavirus G1, live attenuated - ?2.2x106 IU, Rotavirus G2, live attenuated - ?2.8x106 IU, Rotavirus G3, live attenuated - ?2.2x106 IU, Rotavirus G4, live attenuated - ?2.0x106 IU, Rotavirus P1, live attenuated - ?2.3x106 IU		Suspension	4,508,592 L.L
M01AE01	BRUFEN	B	Ibuprofen - 100mg/5ml	100mg/5ml	Syrup	364,181 L.L
N02AA01	MST CONTINUS	B	Morphine sulfate - 60mg	60mg	Tablet, film coated, prolonged release	3,839,358 L.L
N06AA21	MEFIDIOMIL	B	Maprotiline - 25mg	25mg	Tablet, sugar coated	909,973 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	888,280 L.L
J07BH01	ROTARIX ORAL	B	Rota virus human RIX4414, live attenuated - ?106 CCID50		Suspension	5,167,074 L.L
M01AE01	CHILDREN'S ADVIL	B	Ibuprofen - 100mg/5ml	100mg/5ml	Suspension	370,901 L.L
N06AA21	MEFIDIOMIL	B	Maprotiline - 75mg	75mg	Tablet, sugar coated	958,608 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C10AA08	LIVAZO	B	Pitavastatin - 2mg	2mg	Tablet, film coated	1,558,857 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
L01EG02	AFINITOR	B	Everolimus - 10mg	10mg	Tablet	214,897,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 10mg	10mg	Tablet, film coated	593,978 L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg		Tablet, sugar coated, slow release	819,744 L.L
C05CX	REPARIL	B	Aescine - 20mg	20mg	Tablet, sugar coated	510,660 L.L
C09CA08	VOTUM	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	954,128 L.L
C10AA08	LIVAZO	B	Pitavastatin - 4mg	4mg	Tablet, film coated	1,835,305 L.L
J07BK01	VARILRIX + SOLVENT IN SYRINGE	B	Varicella virus, live attenuated - ?1033 PFU	?1033 PFU	Injectable lyophilised powder for solution+diluent	3,473,833 L.L
N03AX14	KEPPRA	B	Levetiracetam - 250mg	250mg	Tablet, film coated	3,240,855 L.L
B03AD04	MALTOFER	B	Iron trivalent (hydroxide polymaltose) - 10mg/ml	50mg/5ml	Syrup	589,947 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	920,532 L.L

...

190